April 15, 2025 — Eric Grunden has joined Intelerad as chief customer officer. In this role, Grunden will lead initiatives to enhance the client experience, improve support systems, and drive operational excellence across all client-facing teams. His leadership will ensure improved service delivery, strengthen client relationships, and support healthcare providers in realizing lasting value from Intelerad’s solutions.

April 14, 2025 —The Society for Imaging Informatics in Medicine (SIIM) Annual Meeting is set to take place May 23 to 25, 2025 in Portland, Oregon.

April 11, 2025 — Contrast-enhanced ultrasound (CEUS) is a safe and accurate diagnostic imaging option for pregnant women who develop a medical problem or a suspicious tumor that typically would be investigated by a contrast enhanced CT or MR scan, according to a new study by Canadian doctors.

April 3, 2025 – Accuray Inc. recently announced  that new data on the clinical use of the CyberKnife System reinforce the device’s broad-based radiation treatment capabilities for central nervous system (CNS) tumors. Malignant brain and other CNS tumors are considered to be some of the most fatal types of cancer and contribute to significant morbidity and mortality in the United States1.

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving clinical and technical research to advance innovation for pediatric care delivery across modalities, including magnetic resonance imaging (MRI), ultrasound, molecular imaging (MI) and computed tomography (CT).

April 7, 2025 — DOSIsoft, a provider of patient-specific imaging and dosimetry software solutions, recently announced the latest release of PLANET Onco Dose version 3.2 – multi-radionuclide, personalized, voxel-based dosimetry platform for SIRT and MRT – has received FDA 510(k) clearance in the U.S. and is now approved for market in EU under CE MDR Mark.

End-to-end, versatile, vendor-neutral, the novel PLANET release is specially designed to integrate multi-radionuclide, implement multi-workflow and support multi-therapy.

April 3, 2025 — Siemens Healthineers and Tower Health have formed a 10-year Value Partnership1 focused on equipment enhancement, technology modernization and improving clinical experience for patients. The Value Partnership will bring comprehensive improvements in diagnostic imaging and digital intelligence tools to radiology, oncology and cardiology across the Tower Health system.

Tower Health is a regional integrated healthcare system that offers compassionate, high-quality, leading-edge healthcare and wellness services to communities in Pennsylvania.

March 31, 2025 — MedStar Georgetown University Hospital is the first hospital in the Washington, D.C. region to offer bedside intestinal ultrasound (IUS) to monitor inflammation in IBD patients. To assess chronic inflammatory diseases of the intestines, like Crohn's disease and ulcerative colitis, patients are traditionally monitored with blood tests, stool studies, MRI or CT scans, and colonoscopies. Those kinds of tests can require bowel preparation, sedation, anesthesia, and radiation.

March 31, 2025 — Neuropathic pain affects up to 10 percent of the global population and can be challenging to manage effectively with existing medications.

April 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced that the FDA has approved an Investigational Device Exemption (IDE) application to initiate a pilot study for the treatment of patients with recurrent glioblastoma (GBM) using the Alpha DaRT technology.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now